Travere Therapeutics Novice Eulerpool

Travere Therapeutics Eulerpool News

Travere Therapeutics Novice o delnici

Travere Therapeutics spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše Travere Therapeutics novice zbiramo in objavljamo tukaj.

• 10. september ·

  Yahoo
  Travere Therapeutics to Present at the 2024 Cantor Global Healthcare Conference
• 10. september ·

  Thefly.com
  Travere Therapeutics price target raised by $5 at Canaccord, here's why
• 6. september ·

  Thefly.com
  Travere Therapeutics price target raised by $1 at BofA, here's why
• 6. september ·

  Seeking Alpha
  Travere gains on full FDA approval for kidney drug Filspari
• 5. september ·

  Yahoo
  Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
• 5. september ·

  GlobeNewswire
  Travere Therapeutics Announces Full FDA Approval of FILSPARI? (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
• 5. september ·

  Thefly.com
  Travere Therapeutics' Filspari in kidney function granted full approval by FDA
• 4. september ·

  Yahoo
  High Growth Tech Stocks To Watch In September 2024
• 4. september ·

  TipRanks
  Buy Rating Affirmed for Travere Therapeutics Amid Positive KDIGO Guideline Developments and Filspari’s Market Potential
• 3. september ·

  TipRanks
  Travere Therapeutics (TVTX) Gets a Buy from Evercore ISI